Scott Becker retweeted
$LLY buyinng $MORF $3.2B - oral integrin for inflammatory bowel disease.
$57 per share. 78% premium.
prnewswire.com/news-releases…
Scott Becker retweeted
Thrilled to announce that the California Public Utilities Commission just approved @Cruise for fared operation 24/7 across all of San Francisco!
It’s a huge milestone for the AV industry, but even more importantly a signal to the country that CA prioritizes progress over our tragic status quo.
We share the CPUC’s commitment to delivering safer, cleaner and more accessible transportation options, and remain committed to collaborating closely with regulators to push toward this critical goal.
Let’s Cruise!
Scott Becker retweeted
Today @TakedaPharma and Nimbus announced a definitive agreement under which Takeda will acquire Nimbus’ highly selective, allosteric TYK2 inhibitor: https://teapawt.net/t.co/R9yULDoeYu
Scott Becker retweeted
Just in case there's any doubt, the answer should be 'yes'!
ed.gr/tta1
Scott Becker retweeted
I have a massive trade deficit with the grocery store so I’ve decided to impose tariffs on Kroger
Scott Becker retweeted
Deep Chem is our effort to bridge the gap between modern Machine Learning methods and researchers in molecular sciences. V2.0 out today, more on the way. @deep_chem teapawt.net/rbhar90/status/9700621…
Scott Becker retweeted
AlphaPoint Unveils New Blockchain Network, CEO Hire https://teapawt.net/t.co/asuuJqELlg
Scott Becker retweeted
“A Different Way — Thoughtful Financing, Or Why We Said ‘No’ to a Lot of Money” — @SachinKamdar muckhacker.com/a-different-w…
Scott Becker retweeted
Gilead offers a glimpse at hard data to back up its $600M investment in Nimbus’ NASH drug
$GILD
endpts.com/gilead-offers-a-g…
Scott Becker retweeted
Excited to unveil Atomic! 3 years in we've created 6 companies that employ 270 people across 3 offices. More to come! teapawt.net/tomiogeron/status/8235…
My story on Jack Abraham's stealthy startup studio: Atomic, With First Fund, Looks to Upend VC Model on.wsj.com/2iWLzPH via @WSJVC
Scott Becker retweeted
Our groundbreaking new initiative will spur growth of a world-class life science cluster in NY.
Check it out: on.ny.gov/2hnl55s
Scott Becker retweeted
Fast biotech: Gilead hands $200M to computational wiz Nimbus as it speeds into PhII NASH trial - endpts.com/fast-biotech-gile…
Scott Becker retweeted
Breakthrough work by a fantastic Nimbus team. teapawt.net/naturemedicine/status/…
A fatty-acid synthesis inhibitor slows tumor growth alone & in combo w/ #chemotherapy in mouse models of #lungcancer go.nature.com/2dkprYM
Scott Becker retweeted
Pres. Obama thinking about ideas for next job: "think about something like precision medicine" bloomberg.com/features/2016-… via @business
Scott Becker retweeted
Vium (formerly Mousera) is launching! Awesome platform. I'm looking forward to learning more. medium.com/@lux_capital/intr…
Scott Becker retweeted
The gene editing trio of $NTLA, $EDIT, and CRISPR Rx have raised >$1B in equity and partnering capital. lifescivc.com/2016/05/riding…
Scott Becker retweeted
Breakthrough status of polio virus killing Glioblastoma
#immunotherapy
cbsnews.com/news/60-minutes-…
Scott Becker retweeted
6/ However, huge adverse selection means Title III equity crowdfunding will select for the most desperate companies mattermark.com/read-fine-pri…
Scott Becker retweeted
The creators of Siri just showed off their next AI assistant, Viv, and it's incredible theverge.com/2016/5/9/116399… @Dagk



























